Active 0 6 0 6 O
meningeal 7 16 7 16 B-chronic_disease
or 17 19 17 19 O
central 20 27 20 27 B-chronic_disease
nervous 28 35 28 35 I-chronic_disease
system 36 42 36 42 I-chronic_disease
disease 43 50 43 50 I-chronic_disease

Acute 0 5 51 56 B-cancer
lymphocytic 6 17 57 68 I-cancer
leukemia 18 26 69 77 I-cancer
( 27 28 78 79 I-cancer
ALL 28 31 79 82 I-cancer
) 31 32 82 83 I-cancer

Acute 0 5 84 89 B-cancer
myelogenous 6 17 90 101 I-cancer
leukemia 18 26 102 110 I-cancer
( 27 28 111 112 I-cancer
AML 28 31 112 115 I-cancer
) 31 32 115 116 I-cancer

Age 0 3 117 120 B-age
â‰¥ 4 5 121 122 O
40 6 8 123 125 B-lower_bound
to 9 11 126 128 O
< 12 13 129 130 O
75 14 16 131 133 B-upper_bound
years 17 22 134 139 I-upper_bound

Any 0 3 140 143 O
of 4 6 144 146 O
the 7 10 147 150 O
following 11 20 151 160 O
high 21 25 161 165 O
risk 26 30 166 170 O
or 31 33 171 173 O
recurrent 34 43 174 183 O
hematological 44 57 184 197 B-cancer
malignancies 58 70 198 210 I-cancer

Chronic 0 7 211 218 B-cancer
lymphocytic 8 19 219 230 I-cancer
leukemia 20 28 231 239 I-cancer
( 29 30 240 241 I-cancer
CLL 30 33 241 244 I-cancer
) 33 34 244 245 I-cancer

Chronic 0 7 246 253 B-cancer
myelogenous 8 19 254 265 I-cancer
leukemia 20 28 266 274 I-cancer
( 29 30 275 276 I-cancer
CML 30 33 276 279 I-cancer
) 33 34 279 280 I-cancer

Determination 0 13 281 294 O
that 14 18 295 299 O
the 19 22 300 303 O
malignancy 23 33 304 314 B-cancer
is 34 36 315 317 O
high 37 41 318 322 O
risk 42 46 323 327 O
will 47 51 328 332 O
be 52 54 333 335 O
made 55 59 336 340 O
by 60 62 341 343 O
the 63 66 344 347 O
investigator 67 79 348 360 O

Hodgkin 0 7 361 368 B-cancer
lymphoma 8 16 369 377 I-cancer
( 17 18 378 379 I-cancer
HL 18 20 379 381 I-cancer
) 20 21 381 382 I-cancer

Investigator 0 12 383 395 O
determination 13 26 396 409 O
that 27 31 410 414 O
the 32 35 415 418 O
patient 36 43 419 426 O
is 44 46 427 429 O
an 47 49 430 432 O
appropriate 50 61 433 444 O
candidate 62 71 445 454 O
for 72 75 455 458 O
reduced 76 83 459 466 B-treatment
intensity 84 93 467 476 I-treatment
allogeneic 94 104 477 487 I-treatment
SCT 105 108 488 491 I-treatment
with 109 113 492 496 O
the 114 117 497 500 O
standard 118 126 501 509 O
Massey 127 133 510 516 B-treatment
Cancer 134 140 517 523 I-treatment
Center 141 147 524 530 I-treatment
- 147 148 530 531 I-treatment
Virginia 148 156 531 539 I-treatment
Commonwealth 157 169 540 552 I-treatment
Health 170 176 553 559 I-treatment
System 177 183 560 566 I-treatment
Bone 184 188 567 571 I-treatment
Marrow 189 195 572 578 I-treatment
Transplant 196 206 579 589 I-treatment
MCC 207 210 590 593 I-treatment
- 210 211 593 594 I-treatment
VCUHS 211 216 594 599 I-treatment
BMT 217 220 600 603 I-treatment
Program 221 228 604 611 I-treatment
regimen 229 236 612 619 I-treatment
employed 237 245 620 628 O
in 246 248 629 631 O
this 249 253 632 636 O
trial 254 259 637 642 O

Karnofsky 0 9 643 652 B-clinical_variable
Performance 10 21 653 664 I-clinical_variable
Status 22 28 665 671 I-clinical_variable
of 29 31 672 674 O
70 32 34 675 677 B-lower_bound
- 34 35 677 678 O
100 35 38 678 681 B-upper_bound
% 38 39 681 682 I-upper_bound

Medical 0 7 683 690 B-chronic_disease
, 7 8 690 691 O
psychological 9 22 692 705 B-chronic_disease
, 22 23 705 706 O
or 24 26 707 709 O
social 27 33 710 716 B-chronic_disease
condition 34 43 717 726 I-chronic_disease
that 44 48 727 731 O
, 48 49 731 732 O
in 50 52 733 735 O
the 53 56 736 739 O
opinion 57 64 740 747 O
of 65 67 748 750 O
the 68 71 751 754 O
investigator 72 84 755 767 O
, 84 85 767 768 O
may 86 89 769 772 O
increase 90 98 773 781 O
the 99 102 782 785 O
patient 103 110 786 793 O
's 110 112 793 795 O
risk 113 117 796 800 O
or 118 120 801 803 O
limit 121 126 804 809 O
the 127 130 810 813 O
patient 131 138 814 821 O
's 138 140 821 823 O
adherence 141 150 824 833 O
with 151 155 834 838 O
study 156 161 839 844 O
requirements 162 174 845 857 O

Multiple 0 8 858 866 B-cancer
myeloma 9 16 867 874 I-cancer
( 17 18 875 876 I-cancer
MM 18 20 876 878 I-cancer
) 20 21 878 879 I-cancer

Myelodysplastic 0 15 880 895 B-cancer
syndrome 16 24 896 904 I-cancer
( 25 26 905 906 I-cancer
MDS 26 29 906 909 I-cancer
) 29 30 909 910 I-cancer

Negative 0 8 911 919 O
serology 9 17 920 928 O
for 18 21 929 932 O
HIV 22 25 933 936 B-chronic_disease

Non 0 3 937 940 B-cancer
- 3 4 940 941 I-cancer
Hodgkin 4 11 941 948 I-cancer
lymphoma 12 20 949 957 I-cancer
( 21 22 958 959 I-cancer
NHL 22 25 959 962 I-cancer
) 25 26 962 963 I-cancer

Patients 0 8 964 972 O
with 9 13 973 977 O
or 14 16 978 980 O
without 17 24 981 988 O
previous 25 33 989 997 B-treatment
myeloablative 34 47 998 1011 I-treatment
autologous 48 58 1012 1022 I-treatment
transplant 59 69 1023 1033 I-treatment

Pregnancy 0 9 1034 1043 B-pregnancy
or 10 12 1044 1046 O
breastfeeding 13 26 1047 1060 O

Previous 0 8 1061 1069 B-treatment
therapeutic 9 20 1070 1081 I-treatment
radiation 21 30 1082 1091 I-treatment
therapy 31 38 1092 1099 I-treatment
( 39 40 1100 1101 I-treatment
RT 40 42 1101 1103 I-treatment
) 42 43 1103 1104 I-treatment
that 44 48 1105 1109 O
exceeds 49 56 1110 1117 O
critical 57 65 1118 1126 O
structure 66 75 1127 1136 O
tolerance 76 85 1137 1146 O
doses 86 91 1147 1152 O
as 92 94 1153 1155 O
determined 95 105 1156 1166 O
by 106 108 1167 1169 O
a 109 110 1170 1171 O
radiation 111 120 1172 1181 O
oncologist 121 131 1182 1192 O

Previous 0 8 1193 1201 B-treatment
therapy 9 16 1202 1209 I-treatment
with 17 21 1210 1214 I-treatment
rabbit 22 28 1215 1221 I-treatment
anti 29 33 1222 1226 I-treatment
- 33 34 1226 1227 I-treatment
thymocyte 34 43 1227 1236 I-treatment
globulin 44 52 1237 1245 I-treatment
( 53 54 1246 1247 I-treatment
ATG 54 57 1247 1250 I-treatment
) 57 58 1250 1251 I-treatment

The 0 3 1252 1255 O
consent 4 11 1256 1263 O
form 12 16 1264 1268 O
must 17 21 1269 1273 O
be 22 24 1274 1276 O
signed 25 31 1277 1283 O
and 32 35 1284 1287 O
dated 36 41 1288 1293 O
prior 42 47 1294 1299 B-treatment
to 48 50 1300 1302 I-treatment
initiation 51 61 1303 1313 I-treatment
of 62 64 1314 1316 I-treatment
SCT 65 68 1317 1320 I-treatment
preparative 69 80 1321 1332 I-treatment
treatments 81 91 1333 1343 I-treatment

Women 0 5 1344 1349 B-gender
who 6 9 1350 1353 O
are 10 13 1354 1357 O
not 14 17 1358 1361 O
postmenopausal 18 32 1362 1376 O
or 33 35 1377 1379 O
have 36 40 1380 1384 O
not 41 44 1385 1388 O
undergone 45 54 1389 1398 O
hysterectomy 55 67 1399 1411 B-treatment
must 68 72 1412 1416 O
have 73 77 1417 1421 O
a 78 79 1422 1423 O
documented 80 90 1424 1434 O
negative 91 99 1435 1443 B-pregnancy
serum 100 105 1444 1449 I-pregnancy
pregnancy 106 115 1450 1459 I-pregnancy
test 116 120 1460 1464 O
per 121 124 1465 1468 O
standard 125 133 1469 1477 O
MCC 134 137 1478 1481 O
- 137 138 1481 1482 O
VCUHS 138 143 1482 1487 O
BMT 144 147 1488 1491 O
Program 148 155 1492 1499 O
guidelines 156 166 1500 1510 O

bacterial 0 9 1511 1520 B-chronic_disease
infection 10 19 1521 1530 I-chronic_disease

fungal 0 6 1531 1537 B-chronic_disease

patients 0 8 1538 1546 O
18 9 11 1547 1549 B-lower_bound
to 12 14 1550 1552 O
39 15 17 1553 1555 B-upper_bound
years 18 23 1556 1561 I-upper_bound
of 24 26 1562 1564 O
age 27 30 1565 1568 B-age
will 31 35 1569 1573 O
be 36 38 1574 1576 O
eligible 39 47 1577 1585 O
only 48 52 1586 1590 O
if 53 55 1591 1593 O
the 56 59 1594 1597 O
investigator 60 72 1598 1610 O
has 73 76 1611 1614 O
determined 77 87 1615 1625 O
that 88 92 1626 1630 O
the 93 96 1631 1634 O
patient 97 104 1635 1642 O
has 105 108 1643 1646 O
comorbidity(ies 109 124 1647 1662 O
) 124 125 1662 1663 O
precluding 126 136 1664 1674 O
conventional 137 149 1675 1687 B-treatment
allogeneic 150 160 1688 1698 I-treatment
transplantation 161 176 1699 1714 I-treatment
with 177 181 1715 1719 O
full 182 186 1720 1724 B-treatment
intensity 187 196 1725 1734 I-treatment
myeloablative 197 210 1735 1748 I-treatment
conditioning 211 223 1749 1761 I-treatment

previous 0 8 1762 1770 B-treatment
treatment 9 18 1771 1780 I-treatment
with 19 23 1781 1785 I-treatment
equine 24 30 1786 1792 I-treatment
ATG 31 34 1793 1796 I-treatment
is 35 37 1797 1799 O
allowed 38 45 1800 1807 O
if 46 48 1808 1810 O
more 49 53 1811 1815 O
than 54 58 1816 1820 O
3 59 60 1821 1822 B-lower_bound
months 61 67 1823 1829 I-lower_bound
ago 68 71 1830 1833 I-lower_bound

revious 0 7 1834 1841 O
myeloablative 8 21 1842 1855 B-treatment
autologous 22 32 1856 1866 I-treatment
transplant 33 43 1867 1877 I-treatment
is 44 46 1878 1880 O
permitted 47 56 1881 1890 O
but 57 60 1891 1894 O
not 61 64 1895 1898 O
required 65 73 1899 1907 O

